S. Marel

New approaches to enzyme replacement therapy for Pompe disease

D. Scott, Valérie Ferreira, Yan Su, 2012 .

Mir‐142‐3p target sequences reduce transgene‐directed immunogenicity following intramuscular adeno‐associated virus 1 vector‐mediated gene delivery

S. Deventer, H. Petry, Valérie Ferreira, 2013, The journal of gene medicine.

Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab‐ and ustekinumab‐treated patients with inflammatory bowel disease—a prospective multicentre cohort study

R. Weersma, F. Hoentjen, M. Pierik, 2020, Alimentary pharmacology & therapeutics.